Call for Paper
The ICOCTD is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.
With a strong focus on Oncology the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Emerging cancer therapeutics and treatments
- Novel drug development in oncology
- Combination therapies for cancer
- Immunotherapy advancements in cancer care
- Targeted therapies in oncology
- Challenges in cancer drug approval
- Role of clinical trials in therapeutics
- Patient access to new treatments
- Biomarkers in therapeutic decision-making
- Pharmacogenomics in cancer treatment
- Cost-effectiveness of cancer therapies
- Innovations in radiation oncology
- Palliative care and cancer therapeutics
- Ethical considerations in drug development
- Role of technology in cancer therapeutics
- Long-term outcomes of cancer treatments
- Global access to cancer therapies
- Patient adherence to cancer treatment
- Future trends in cancer therapeutics
- Collaboration in drug development research
Peer Review & Quality
All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.
Registration
Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.
Publication
High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.